StockData
Novo Nordisk A S logo

Novo Nordisk A S

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)

Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –

Novo Nordisk A S Parent Company by Year

Parent Company — Sales and distribution costs (DKKm)

Novo Nordisk A S Parent Company: 49,129.00 DKKm in FY2025, up 0.4% from a year earlier.

Latest, FY2025
49,129.00
Period ended Dec 31, 2025
Change on a year earlier
+0.4%
48,921.00 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below

Where the FY2025 figure comes from

“|| Sales and distribution costs | 3 | (49,129) | (48,921)”

Source: Form 20-F (filed 2026-02-04) ↗

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedParent Company — Sales and distribution costs (DKKm)Year on yearSource
FY2025Dec 31, 202549,129.00+0.4%Form 20-F (filed 2026-02-04) ↗
FY2024Dec 31, 202448,921.00+15.7%Form 20-F (filed 2026-02-04) ↗
FY2023Dec 31, 202342,291.00+12.8%Form 20-F (filed 2025-02-05) ↗
FY2022Dec 31, 202237,476.00+24.8%Form 20-F (filed 2024-01-31) ↗
FY2021Dec 31, 202130,021.00+12.6%Form 20-F (filed 2023-02-01) ↗
FY2020Dec 31, 202026,673.00+12.9%Form 20-F (filed 2022-02-02) ↗
FY2019Dec 31, 201923,619.00–Form 6-K (filed 2021-02-03) ↗

Cite this data

StockData. (2026). Novo Nordisk A S Parent Company, annual FY2019–FY2025 [Data set]. Compiled from Novo Nordisk A S SEC filings and investor materials. https://stockdatahq.com/stocks/nvo/kpis/parent-sd-costs

See every metric in the Novo Nordisk A S KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?